Skip to main content
. 2021 May 3;31(5):740–751. doi: 10.1089/thy.2020.0679

Table 2.

Patient Characteristics of the Studies Included in the Systematic Review

Study Sample size (n) Age (years) Women (%) Were all patients euthyroid at TH discontinuation LT4 dose at discontinuation (mcg/day) Treatment duration (years) Thyroid antibodies TPO and/or anti-TG Ab (%) Goiter (%) Heterogeneous gland (%) Family history of thyroid disease (%)
Children and adolescents
 Sklar (37) 16 Unclear   Median 2.2 100
 Battelino et al. (25) 29 Mean 14.9
Range 8.5–19.7
79 Yes
 Wasniewska et al. (36) 69 9.4 (4.0)
Range 2.1–14.9
75.4 Yes 2 7.2a 0 7.2
 Radetti et al. (26) 148 82.6 No 4.1 (2.6)
Range 1–12
100 100 47.7
Children, adolescents, and adults
 Takasu et al. (39) 92 Range 14–68 90.2 Yes Mean 3.8
Range 1–8
100 100
 Takasu et al. (35) 21 31 [12–72]b 85.7 Yes Range 1.5–7 33.3
 Fava et al. (38) 14 18 [8–26]b 78.6 Yes 1.26 (0.3)c 6.4 [2.8–12.4]b 42.9 100 21.4
Adults
 Krugman et al. (29) 14 Range 17–68 71 Unknown Range 0.4–22 21.4
 Ohsawa et al. (30) 24 100 Unknown LT4: 200
LT3: 50
Range 0.1–5 100
 Rizzolo et al. (41) 22 Unknown
 Nikolai (34) 49 Mean 52
Range 23–81
79.6 Unclear Range 0.5–3 38.8
 Rieu et al. (33) 20 Yes 1 100
 Comtois et al. (32) 79 39 (13)
Range 17–64
91 Yes 110 (30)
Range 50–150
1 55.7 44
 Carlwe et al. (40) 13 Mean 43
Range 28–60
92 Yes 109 [75–162)]
 Höfling et al. (31) 20 42.1 (11.6) 100 Yes Mean 90.00 [CI 70.87–109.13] 4.52 (3.47) 90a
80d
25 100
 Rosario and Calsolari (27) 182 42 [19–63]b 100 Yes Range 25–100
Range 0.3–1.5c
3 [2–6.8]b 55a 23.1
 Livadas et al. (24) 291 48 (16.4) 84 Yes 0.92 (0.42)c Mean 8.1
Range 1–37
58 0 62 63

Results are mean (SD), unless otherwise indicated.

a

TPO Ab only.

b

Results are median [range].

c

Results are mcg/kg/day.

d

Anti-TG Ab only.

anti-TG Ab, anti-thyroglobulin antibody; CI, 95% confidence interval; LT3, liothyronine; LT4, levothyroxine; TH, thyroid hormone; TPO, thyroid peroxidase; TPO Ab, thyroid peroxidase antibody.